FCGR3A and psoriatic arthritis: Abatacept is an immunosuppressant, which is used for the treatment of rheumatoid arthritis, psoriatic arthritis, and juvenile idiopathic arthritis, and FCGR3A can affect the response to abatacept treatment in rheumatoid arthritis (14).